(Q42469215)

1 November 2017

title

Effects of dotarizine and flunarizine on chromaffin cell viability and cytosolic Ca2+. (English)

1 reference

1 November 2017

1 reference

ChEBI release 2020-05-28

ChEBI ID

138033

author

Francisco Abad-Santos

2

1 reference

1 November 2017

3

1 reference

1 November 2017

Novalbos J

1

1 reference

1 November 2017

Cano-Abad MF

4

1 reference

1 November 2017

Moradiellos J

5

1 reference

1 November 2017

Sánchez-García P

6

1 reference

1 November 2017

García AG

7

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

European Journal of Pharmacology

1 November 2017

published in

1 reference

1 November 2017

volume

366

1 reference

1 November 2017

issue

2-3

1 reference

1 November 2017

page(s)

309-317

1 reference

Extracellular ions during veratridine-induced neurotoxicity in hippocampal slices: neuroprotective effects of flunarizine and tetrodotoxin

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Open dose-ranging trial of flunarizine as add-on therapy in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

D2 receptor blockade by flunarizine and cinnarizine explains extrapyramidal side effects. A SPECT study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Effects of dotarizine on peripheral and pulmonary circulation and cardiac dynamics in dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Glutamate neurotoxicity and diseases of the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Diagnosis and management of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Programmed cell death: its possible contribution to neurotoxicity mediated by calcium channel antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Role of Ca2+ channels in the ability of membrane depolarization to prevent neuronal death induced by trophic-factor deprivation: evidence that levels of internal Ca2+ determine nerve growth factor dependence of sympathetic ganglion cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

`Wide-spectrum Ca2+ channel antagonists': lipophilicity, inhibition, and recovery of secretion in chromaffin cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Adrenal medullary chromaffin cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Veratridine-induced oscillations of cytosolic calcium and membrane potential in bovine chromaffin cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Links between long-term potentiation and neuropathology. An hypothesis involving calcium-activated proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Flunarizine- and cinnarizine-induced extrapyramidal reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Separation and culture of living adrenaline- and noradrenaline-containing cells from bovine adrenal medullae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Ca++ and Na+ channels involved in neuronal cell death. Protection by flunarizine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Flunarizine protects neurons from death after axotomy or NGF deprivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Phosphatidylserine monolayers as models for drug uptake into membranes and tissue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Effects of dotarizine on 45Ca2+ movements and contractile responses in vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Binding of the calcium antagonist flunarizine to phosphatidylcholine bilayers: charge effects and thermodynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

Dotarizine versus flunarizine as calcium antagonists in chromaffin cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

7 January 2021

Drug therapy of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900916-9

10.1016/S0014-2999(98)00916-9

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference